The Latest Cardiac and Vascular News
JANUARY 17, 2025 – Medtronic, a global leader in healthcare technology, today announced new data and case presentations for the company’s pulsed field ablation (PFA) technologies, Affera™ Mapping and Ablation System with Sphere-9™ Catheter and PulseSelect™, to be presented at the AF Symposium in Boston, MA. “We are encouraged by the […]
Expanded relationship includes joint research studies to test the feasibility of a combined electrocardiogram and magnetocardiogram approach using SandboxAQ’s Quantitative AI to integrate and interpret the results PALO ALTO, Calif., Jan. 17, 2025 /PRNewswire/ — SandboxAQ, a leader in…
First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Ablation System Sub-analysis from OPTION clinical trial highlights consistent safety and…
Abstract presentation will feature the first clinical use of the company’s CLAAS® AcuFORM™ Left Atrial Appendage Occlusion (LAAO) Device NASHUA, N.H., Jan. 16, 2025 /PRNewswire/ — Conformal Medical, Inc., today announced that the early results of its GLACE Study will be presented during…
MARLBOROUGH, Mass.–(BUSINESS WIRE)–CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac arrhythmias, today announced the publication of the 12-month results from the ECLIPSE AF trial in Circulation: Arrhythmia & Electrophysiology, demonstrating an overall 90.2% 12-month freedom from clinically significant atrial arrhythmia among paroxysmal atrial fibrillation (AF) patients undergoing […]
COPENHAGEN, Denmark, Jan. 15, 2025 /PRNewswire/ — CathVision, a leader in advanced electrophysiology (EP) solutions, is excited to announce its participation in the AF Symposium in Boston this January. Renowned for its innovative technology and strong dedication to advancing EP labs…
REDWOOD CITY, Calif. and BELFAST, Northern Ireland, Jan. 15, 2025 /PRNewswire/ — Biotricity Inc. (OTCQB:BTCY), a provider of remote cardiac monitoring solutions, and B-Secur, a leader in biosensing technology, have joined forces to create one of the most advanced, device-neutral…
Powered by AliveCor’s proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings to detect 35 cardiac determinations, including heart attack. MOUNTAIN VIEW, Calif., Jan. 14, 2025 /PRNewswire/ — AliveCor, the global leader in…
ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at Oulu University Hospital in Finland have successfully treated the first patients using the advanced Genesis Robotic Magnetic Navigation (RMN) System from Stereotaxis.
DUBLIN, Jan. 14, 2025 /PRNewswire/ — LUMA Vision Ltd., an innovative leader in Cardiac Navigation and Visualization technology, proudly announces the successful first-in-human use and enrollment in its LUMINIZE clinical study, using the groundbreaking VERAFEYE™ platform. This…
